THIO

The Safety of THIO Sequenced With Cemiplimab in NSCLC Remains Promising

The Safety of THIO Sequenced With Cemiplimab in NSCLC Remains Promising

SG Tylor

Source – MAIA Biotechnology Two patients with advanced non-small cell lung cancer (NSCLC) have not experienced disease progression for 12.2 ...